VETOQUINOL IS MOVING FORWARD WITH THE ACQUISITION OF PROFENDER® AND DRONTAL® AND RELATED PIPELINE ASSETS FOLLOWING COMMUNICATION FROM THE EUROPEAN COMMISSION
June 9th, 2020 (Lure, France) - The European Commission (EC) has approved, under the EU merger Regulation, the proposed acquisition of Bayer’s Animal Health Division by Elanco Animal Health. This EC decision is conditional on the divestment of several products, including the Profender® and Drontal® product families, as well as the related pipeline assets, to be acquired by Vetoquinol.
- Public releases
Vetoquinol has been listed on the Euronext Paris stock market since November 16th.
Composition of the bodies of Corporate Management and Governance
Financial information and key figures: annual, half-year and by sector key figures